과제정보
연구 과제 주관 기관 : National Research Foundation of Korea (NRF)
참고문헌
- Agirre X, Roman-Gomez J, Vazquez I, Jimenez-Velasco A, Garate L, Montiel-Duarte C, Artieda P, Cordeu L, Lahortiga I, Calasanz MJ, Heiniger A, Torres A, Minna JD, Prosper F. Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia. Int J Cancer. 2006. 118: 1945-1953. https://doi.org/10.1002/ijc.21584
- Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009. 9: 361-371. https://doi.org/10.1038/nrc2628
- Borghaei RC, Gorski G, Javadi M. NF-kappaB and ZBP-89 regulate MMP-3 expression via a polymorphic site in the promoter. Biochem Biophys Res Commun. 2009. 382: 269-273. https://doi.org/10.1016/j.bbrc.2009.03.002
- Choi DH, Kim EM, Son HJ, Joh TH, Kim YS, Kim D, Flint Beal M, Hwang O. A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells. J Neurochem. 2008. 106: 405-415. https://doi.org/10.1111/j.1471-4159.2008.05399.x
- Denison SR, Callahan G, Becker NA, Phillips LA, Smith DI. Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer. Genes Chromosomes Cancer. 2003a. 38: 40-52. https://doi.org/10.1002/gcc.10236
- Denison SR, Wang F, Becker NA, Schule B, Kock N, Phillips LA, Klein C, Smith DI. Alterations in the common fragile site gene Parkin in ovarian and other cancers. Oncogene. 2003b. 22: 8370-8378. https://doi.org/10.1038/sj.onc.1207072
- Fesik SW, Shi Y. Structural biology. Controlling the caspases. Science. 2001. 294: 1477-1478. https://doi.org/10.1126/science.1062236
- Franco DL, Nojek IM, Molinero L, Coso OA, Costas MA. Osmotic stress sensitizes naturally resistant cells to TNF-alpha-induced apoptosis. Cell Death Differ. 2002. 9: 1090-1098. https://doi.org/10.1038/sj.cdd.4401074
- Hosseini M, Rose AY, Song K, Bohan C, Alexander JP, Kelley MJ, Acott TS. IL-1 and TNF induction of matrix metalloproteinase- 3 by c-Jun N-terminal kinase in trabecular meshwork. Invest Ophthalmol Vis Sci. 2006. 47: 1469-1476. https://doi.org/10.1167/iovs.05-0451
- Kim EM, Shin EJ, Choi JH, Son HJ, Park IS, Joh TH, Hwang O. Matrix metalloproteinase-3 is increased and participates in neuronal apoptotic signaling downstream of caspase-12 during endoplasmic reticulum stress. J Biol Chem. 2010. 285: 16444 -16452. https://doi.org/10.1074/jbc.M109.093799
- Kim YS, Patel S, Lee SJ. Lack of direct role of parkin in the steady-state level and aggregation of alpha-synuclein and the clearance of pre-formed aggregates. Exp Neurol. 2006. 197: 538-541. https://doi.org/10.1016/j.expneurol.2005.10.024
- Kimura K, Orita T, Kondo Y, Zhou H, Nishida T. Upregulation of matrix metalloproteinase expression by poly(I:C) in corneal fibroblasts: role of NF-kappaB and interleukin-1ss. Invest Ophthalmol Vis Sci. 2010. 51: 5012-5018. https://doi.org/10.1167/iovs.10-5167
- Kong FM, Anscher MS, Washington MK, Killian JK, Jirtle RL. M6P/IGF2R is mutated in squamous cell carcinoma of the lung. Oncogene. 2000. 19: 1572-1578. https://doi.org/10.1038/sj.onc.1203437
- Lee KH, Lee MH, Kang YW, Rhee K-J, Kim TU, Kim YS. Parkin induces apoptotic cell death in TNF-a-treated cervical cancer cells. BMB Rep. 2012. 45: 526-531 https://doi.org/10.5483/BMBRep.2012.45.9.104
-
Lee KH, Lee MH, Lee IS, Rhee K-J, Kim YS. Parkin reduces Expression of Monocytes Chemotactic protein-1 (MCP-1) in TNF-
${\alpha}$ -stimulated MCF7 Breast cancer cells. J Exp Biomed Sci. 2011. 17: 261-265. - Murphy G, Nagase H. Progress in matrix metalloproteinase research. Mol Aspects Med. 2008. 29: 290-308. https://doi.org/10.1016/j.mam.2008.05.002
- Oates AJ, Schumaker LM, Jenkins SB, Pearce AA, DaCosta SA, Arun B, Ellis MJ. The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene. Breast Cancer Res Treat. 1998. 47: 269-281. https://doi.org/10.1023/A:1005959218524
- Philipson L, Pettersson U, Lindberg U. Molecular biology of adenoviruses. Virol Monogr. 1975. 14: 1-115.
- Picchio MC, Martin ES, Cesari R, Calin GA, Yendamuri S, Kuroki T, Pentimalli F, Sarti M, Yoder K, Kaiser LR, Fishel R, Croce CM. Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer. Clin Cancer Res. 2004. 10: 2720-2724. https://doi.org/10.1158/1078-0432.CCR-03-0086
- Poulogiannis G, McIntyre RE, Dimitriadi M, Apps JR, Wilson CH, Ichimura K, Luo F, Cantley LC, Wyllie AH, Adams DJ, Arends MJ. PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice. Proc Natl Acad Sci U S A. 2010. 107: 15145-15150. https://doi.org/10.1073/pnas.1009941107
- Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R, Mizuno Y, Kosik KS, Selkoe DJ. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science. 2001. 293: 263-269. https://doi.org/10.1126/science.1060627
- Shridhar V, Staub J, Huntley B, Cliby W, Jenkins R, Pass HI, Hartmann L, Smith DI. A novel region of deletion on chromosome 6q23.3 spanning less than 500 Kb in high grade invasive epithelial ovarian cancer. Oncogene. 1999. 18: 3913-3918. https://doi.org/10.1038/sj.onc.1202756
- Tay SP, Yeo CW, Chai C, Chua PJ, Tan HM, Ang AX, Yip DL, Sung JX, Tan PH, Bay BH, Wong SH, Tang C, Tan JM, Lim KL. Parkin enhances the expression of cyclin-dependent kinase 6 and negatively regulates the proliferation of breast cancer cells. J Biol Chem. 2010. 285: 29231-29238. https://doi.org/10.1074/jbc.M110.108241
- Van Lint P, Libert C. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol. 2007. 82: 1375-1381. https://doi.org/10.1189/jlb.0607338
- Veeriah S, Taylor BS, Meng S, Fang F, Yilmaz E, Vivanco I, Janakiraman M, Schultz N, Hanrahan AJ, Pao W, Ladanyi M, Sander C, Heguy A, Holland EC, Paty PB, Mischel PS, Liau L, Cloughesy TF, Mellinghoff IK, Solit DB, Chan TA. Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat Genet. 2010. 42: 77-82. https://doi.org/10.1038/ng.491
- Wang F, Denison S, Lai JP, Philips LA, Montoya D, Kock N, Schule B, Klein C, Shridhar V, Roberts LR, Smith DI. Parkin gene alterations in hepatocellular carcinoma. Genes Chromosomes Cancer. 2004. 40: 85-96. https://doi.org/10.1002/gcc.20020
- Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem. 1996. 271: 13055-13060. https://doi.org/10.1074/jbc.271.22.13055